Thermo Fisher Scientific has unveiled an off-the-shelf validated software solution to automate cell therapy manufacturing workflows. The new software, called Gibco CTS Cellmation Software, connects and integrates workflows across multiple Thermo Fisher Scientific cell therapy instruments, reducing manual touchpoints and enabling traceability, repeatability, and 21 CFR Part 11 compliance. It aims to save time and resources in the cell therapy manufacturing process, helping to deliver curative therapies more quickly and safely to patients. Thermo Fisher Scientific is committed to streamlining manufacturing for cell therapy developers, and all cell therapy platforms currently in development will align with and connect to this digital, automated framework.+